Advertisement
Lantheus Holdings, Inc.

Lantheus Holdings, Inc. (LNTH) Stock Overview

Explore Lantheus Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LNTHNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$104.52
$0.20(0.19%)
U.S. Market opens in 53h 40m
Advertisement

Lantheus Holdings, Inc. (LNTH)

Meyka AI Score

Z

Key Financials

Market Cap6.8B
P/E Ratio24.15
EPS (TTM)$4.19
ROE0.24%
Fundamental Analysis

AI Price Forecasts

1 Month$66.10
3 Months$42.81
1 Year Target$63.08

LNTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lantheus Holdings, Inc. (LNTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $63.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.15 and a market capitalization of 6.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.19%
5-Day Change
1.90%
1-Month Change
8.61%
3-Month Change
29.97%
6-Month Change
56.89%
Year-to-Date (YTD) Change
57.05%
1-Year Change
30.42%
3-Year Change
24.46%
5-Year Change
330.30%
All-Time (Max) Change
1443.87%

Contact Information

978 671 8001
331 Treble Cove Road, Bedford, MA, 01862

Company Facts

808 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions